Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Amgen's FOLR1-BiTE antibody constructs target folate receptor 1 in ovarian tumors

May 25, 2016

Linaclotide shows preclinical potential for bladder hyperactivity

May 25, 2016

Mixed results for KRP-203 in ulcerative colitis phase II trial

May 25, 2016

ZVex/mIL12 shows promising antitumor effect in vivo

May 24, 2016

Catabasis' SREBP inhibitors show potential for NASH

May 24, 2016

Vasohibin-1 shows promise as a therapeutic target for diabetic erectile dysfunction

May 24, 2016

TRIP-13 identified as a therapeutic target in hepatocellular carcinoma

May 24, 2016

Mersana's XMT-1536 targets tumors expressing sodium-dependent phosphate transport protein 2B

May 24, 2016

Mutations in ZAS may be associated with congenital myopathy

May 24, 2016

NMDA receptor antagonist for colitis

May 23, 2016

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...